Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Millions.
The item "Minority-Interest-Expense" stands at 43.00 Million Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 6.00 Million EUR for the item "Minority Interest Expense" represents an increase of 50.00 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 6.00 Million EUR for the item "Minority Interest Expense" represents a decrease of -79.31 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 43.00 Million EUR for the item "Minority Interest Expense" represents a decrease of -34.85 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.
The 1 year change is 0.0 Million Euros.
The 3 year change is -23.00 Million Euros.
The 5 year change is 727.00 Million Euros.
The 10 year change is 160.00 Million Euros.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Minority Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Minority Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Minority Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Minority Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Minority Interest Expense | 280,205,508,085.11 |